{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T19:40:33Z","timestamp":1788896433629,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,5,23]],"date-time":"2027-05-23T00:00:00Z","timestamp":1811030400000},"content-version":"am","delay-in-days":326,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["K76AG083287"],"award-info":[{"award-number":["K76AG083287"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpsmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pain and Symptom Management"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jpainsymman.2026.03.015","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:42:20Z","timestamp":1774658540000},"page":"e58-e63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Psychostimulants for Depression in Serious Illness: Limited Evidence, Select Indications"],"prefix":"10.1016","volume":"72","author":[{"given":"Karolina","family":"Sadowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6219-7619","authenticated-orcid":false,"given":"Danielle","family":"Chammas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mia","family":"Pattillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2921-1421","authenticated-orcid":false,"given":"Cara L.","family":"McDermott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8255-9374","authenticated-orcid":false,"given":"Nneka N.","family":"Ufere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4048-9499","authenticated-orcid":false,"given":"Jason A.","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8168-2255","authenticated-orcid":false,"given":"Daniel","family":"Shalev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpainsymman.2026.03.015_bib0001","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1080\/14656566.2016.1182986","article-title":"Methylphenidate HCL for the treatment of ADHD in children and adolescents","volume":"17","author":"Childress","year":"2016","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.jpainsymman.2026.03.015_bib0002","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jad.2021.05.119","article-title":"Comparative efficacy and safety of stimulant-type medications for depression: a systematic review and network meta-analysis","volume":"292","author":"Bahji","year":"2021","journal-title":"J Affect Disord"},{"key":"10.1016\/j.jpainsymman.2026.03.015_bib0003","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/JCP.0000000000000723","article-title":"The efficacy of psychostimulants in major depressive episodes: a systematic review and meta-analysis","volume":"37","author":"McIntyre","year":"2017","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.jpainsymman.2026.03.015_bib0004","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/HRP.0000000000000197","article-title":"The Psychopharmacology Algorithm Project at the Harvard South Shore Program: an update on Unipolar nonpsychotic depression","volume":"27","author":"Giakoumatos","year":"2019","journal-title":"Harv Rev Psychiatry"},{"key":"10.1016\/j.jpainsymman.2026.03.015_bib0005","series-title":"Depression in adults: Treatment and management","year":"2022"},{"key":"10.1016\/j.jpainsymman.2026.03.015_bib0006","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/s40501-023-00307-4","article-title":"Psychostimulant augmentation of antidepressant therapy in depression: a systematic review and meta-analysis","volume":"10","author":"Janela","year":"2023","journal-title":"Curr Treat Options Psychiatry"},{"key":"10.1016\/j.jpainsymman.2026.03.015_bib0007","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/da.22249","article-title":"What is the threshold for a clinically relevant effect? The case of major depressive disorders","volume":"31","author":"Cuijpers","year":"2014","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.jpainsymman.2026.03.015_bib0008","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0033-3182(96)71599-2","article-title":"Psychostimulants for depression in hospitalized cancer patients","volume":"37","author":"Olin","year":"1996","journal-title":"Psychosomatics"},{"key":"10.1016\/j.jpainsymman.2026.03.015_bib0009","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1177\/104990910001700610","article-title":"Methylphenidate for depression in hospice practice: a case series","volume":"17","author":"Homsi","year":"2000","journal-title":"Am J Hosp Palliat Med"},{"key":"10.1016\/j.jpainsymman.2026.03.015_bib0010","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.amjopharm.2009.02.006","article-title":"Methylphenidate for treatment of depressive symptoms, apathy, and fatigue in medically ill older adults and terminally ill adults","volume":"7","author":"Hardy","year":"2009","journal-title":"Am J Geriatr Pharmacother"},{"issue":"2","key":"10.1016\/j.jpainsymman.2026.03.015_bib0011","first-page":"CD006722","article-title":"Psychostimulants for depression","author":"Candy","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jpainsymman.2026.03.015_bib0012","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.4088\/JCP.13r08560","article-title":"Modafinil augmentation therapy in unipolar and bipolar depression: a systematic review and meta-analysis of randomized controlled trials","volume":"74","author":"Goss","year":"2013","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jpainsymman.2026.03.015_bib0013","first-page":"30S","article-title":"A review of psychostimulants for adults with depression","volume":"32","author":"Pary","year":"2015","journal-title":"Fed Pract Health Care Prof VA DoD PHS"},{"key":"10.1016\/j.jpainsymman.2026.03.015_bib0014","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.19r12767","article-title":"The potential procognitive effects of modafinil in major depressive disorder: a systematic review","volume":"80","author":"Vaccarino","year":"2019","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jpainsymman.2026.03.015_bib0015","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jpainsymman.2011.03.026","article-title":"Effects of methylphenidate on fatigue and depression: a randomized, double-blind, placebo-controlled trial","volume":"43","author":"Kerr","year":"2012","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2026.03.015_bib0016","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1136\/bmjspcare-2011-000093","article-title":"Multicentre, double-blind, randomised placebo-controlled clinical trial on the efficacy of methylphenidate on depressive symptoms in advanced cancer patients","volume":"2","author":"C","year":"2012","journal-title":"BMJ Support Palliat Care"},{"key":"10.1016\/j.jpainsymman.2026.03.015_bib0017","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/JCP.0000000000000442","article-title":"Modafinil moderates the relationship between cancer-related fatigue and depression in 541 patients receiving chemotherapy","volume":"36","author":"Conley","year":"2016","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.jpainsymman.2026.03.015_bib0018","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1002\/cncr.25083","article-title":"A phase III randomized, placebo-controlled, double-blind clinical trial of the effect of modafinil on cancer-related fatigue among 631 patients receiving chemotherapy: a URCC CCOP research base study","volume":"116","author":"Jean-Pierre","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.jpainsymman.2026.03.015_bib0019","first-page":"2382","article-title":"Methylphenidate versus placebo for treating fatigue in patients with advanced cancer: randomized, double-blind, multicenter, placebo-controlled trial","volume":"42","author":"Stone","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jpainsymman.2026.03.015_bib0020","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1200\/JCO.2012.45.3696","article-title":"Methylphenidate and\/or a nursing telephone intervention for fatigue in patients with advanced cancer: a randomized, placebo-controlled, phase II trial","volume":"31","author":"Bruera","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jpainsymman.2026.03.015_bib0021","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1093\/neuonc\/not102","article-title":"The effect of modafinil on fatigue, cognitive functioning, and mood in primary brain tumor patients: a multicenter randomized controlled trial","volume":"15","author":"Boele","year":"2013","journal-title":"Neuro-Oncol"},{"key":"10.1016\/j.jpainsymman.2026.03.015_bib0022","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1200\/JCO.2013.54.4346","article-title":"Modafinil for the treatment of fatigue in lung cancer: results of a placebo-controlled, double-blind, randomized trial","volume":"32","author":"Spathis","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jpainsymman.2026.03.015_bib0023","doi-asserted-by":"crossref","first-page":"e377","DOI":"10.1016\/j.jpainsymman.2025.11.014","article-title":"Methylphenidate for depression in advanced cancer: exploratory meta-analysis of randomized trials","volume":"71","author":"Costa","year":"2026","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2026.03.015_bib0024","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.euroneuro.2014.01.016","article-title":"Rapid response to methylphenidate as an add-on therapy to mirtazapine in the treatment of major depressive disorder in terminally ill cancer patients: a four-week, randomized, double-blinded, placebo-controlled study","volume":"24","author":"Ng","year":"2014","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.jpainsymman.2026.03.015_bib0025","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1002\/pon.4220","article-title":"Randomized, double-blind, placebo-controlled study of methylphenidate for the treatment of depression in SSRI-treated cancer patients receiving palliative care","volume":"26","author":"Sullivan","year":"2017","journal-title":"Psychooncology"},{"key":"10.1016\/j.jpainsymman.2026.03.015_bib0026","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0033-3182(87)72476-1","article-title":"Methylphenidate for depressive disorders in cancer patients","volume":"28","author":"Fernandez","year":"1987","journal-title":"Psychosomatics"},{"key":"10.1016\/j.jpainsymman.2026.03.015_bib0027","first-page":"263","article-title":"Methylphenidate in depressed medically ill patients","volume":"52","author":"Rosenberg","year":"1991","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jpainsymman.2026.03.015_bib0028","doi-asserted-by":"crossref","first-page":"750","DOI":"10.4088\/JCP.v61n1007","article-title":"Treatment of depression with methylphenidate in patients difficult to wean from mechanical ventilation in the intensive cCare unit","volume":"61","author":"Rothenhausler","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jpainsymman.2026.03.015_bib0029","first-page":"12","article-title":"Psychostimulant treatment of depressive disorders secondary to medical illness","volume":"47","author":"Woods","year":"1986","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jpainsymman.2026.03.015_bib0030","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0033-3182(91)72093-8","article-title":"Psychostimulants for secondary depression in medical illness","volume":"32","author":"Masand","year":"1991","journal-title":"Psychosomatics"},{"key":"10.1016\/j.jpainsymman.2026.03.015_bib0031","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jpainsymman.2010.09.004","article-title":"Psychostimulants","volume":"40","author":"Howard","year":"2010","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2026.03.015_bib0032","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1161\/CIR.0000000000000426","article-title":"Drugs that may cause or exacerbate heart failure: a scientific statement from the American Heart Association","volume":"134","author":"Page","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jpainsymman.2026.03.015_bib0033","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.9492","article-title":"Safety of stimulants across patient populations: a meta-analysis","volume":"8","author":"Oliva","year":"2025","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jpainsymman.2026.03.015_bib0034","doi-asserted-by":"crossref","first-page":"e167","DOI":"10.1097\/MJT.0000000000000387","article-title":"A randomized, placebo-controlled clinical trial of efficacy and safety: modafinil in the treatment of fatigue in patients with primary biliary cirrhosis","volume":"24","author":"Silveira","year":"2017","journal-title":"Am J Ther"},{"key":"10.1016\/j.jpainsymman.2026.03.015_bib0035","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3109\/08039488.2012.752035","article-title":"Psychostimulants in moderate to severe affective disorder: a systematic review of randomized controlled trials","volume":"67","author":"Abbasowa","year":"2013","journal-title":"Nord J Psychiatry"},{"key":"10.1016\/j.jpainsymman.2026.03.015_bib0036","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1089\/jpm.2020.0659","article-title":"Evidence-based management of depression in palliative care: a systematic review","volume":"24","author":"Perusinghe","year":"2021","journal-title":"J Palliat Med"},{"key":"10.1016\/j.jpainsymman.2026.03.015_bib0037","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1056\/NEJMoa2304145","article-title":"Esketamine nasal spray versus Quetiapine for treatment-resistant depression","volume":"389","author":"Reif","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpainsymman.2026.03.015_bib0038","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jad.2021.12.134","article-title":"Augmentation strategies for treatment resistant major depression: a systematic review and network meta-analysis","volume":"302","author":"Nu\u00f1ez","year":"2022","journal-title":"J Affect Disord"},{"key":"10.1016\/j.jpainsymman.2026.03.015_bib0039","doi-asserted-by":"crossref","first-page":"209","DOI":"10.7326\/0003-4819-132-3-200002010-00007","article-title":"for the ACP-ASIM End-of-life Care Consensus Panel. Assessing and managing depression in the terminally ill patient","volume":"132","author":"Block","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jpainsymman.2026.03.015_bib0041","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2165\/00023210-200721030-00004","article-title":"Psychostimulants in the treatment of depression: a review of the evidence","volume":"21","author":"Orr","year":"2007","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jpainsymman.2026.03.015_bib0042","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1177\/104990910101800610","article-title":"A phase II study of methylphenidate for depression in advanced cancer","volume":"18","author":"Homsi","year":"2001","journal-title":"Am J Hosp Palliat Med"},{"key":"10.1016\/j.jpainsymman.2026.03.015_bib0043","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1200\/JCO.1998.16.7.2522","article-title":"Methylphenidate therapy improves cognition, mood, and function of brain tumor patients","volume":"16","author":"Meyers","year":"1998","journal-title":"J Clin Oncol"}],"container-title":["Journal of Pain and Symptom Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392426001272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392426001272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T20:14:12Z","timestamp":1779999252000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0885392426001272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0885392426001272"],"URL":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2026.03.015","relation":{},"ISSN":["0885-3924"],"issn-type":[{"value":"0885-3924","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psychostimulants for Depression in Serious Illness: Limited Evidence, Select Indications","name":"articletitle","label":"Article Title"},{"value":"Journal of Pain and Symptom Management","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2026.03.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}